STAAR Surgical Company (STAA)

Currency in USD
26.55
-0.79(-2.89%)
Closed·
26.550.00(0.00%)
·
Advertisement
STAA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
25.8927.41
52 wk Range
15.5935.87
Key Statistics
Prev. Close
27.34
Open
27.34
Day's Range
25.89-27.41
52 wk Range
15.59-35.87
Volume
796.6K
Average Volume (3m)
959.08K
1-Year Change
57.0077%
Book Value / Share
7.12
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
STAA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
29.67
Upside
+11.74%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

STAAR Surgical Company News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

3 Buy
8 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 29.67
(+11.74% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Piper Sandler
Hold33.00+24.29%16.00Maintain14/05/2026
Wedbush
Buy40.00+50.66%-Upgrade14/05/2026
Canaccord
Buy32.00+20.53%27.00Maintain14/05/2026
Mizuho
Hold27.00+1.69%22.00Maintain14/05/2026
Stifel
Hold31.00+16.76%18.00Maintain14/05/2026

STAAR Surgical Company Earnings Call Summary for Q1/2026

  • STAAR Surgical Q1 2026 EPS of $0.10 doubled forecasts; revenue hit $93.5M, up 119.6% YoY, beating estimates by 18.75%.
  • China sales drove growth at $47.4M; U.S. market exceeded $6M quarterly for first time; gross margin improved to 73.6% from 65.8%.
  • Adjusted EBITDA turned positive at $24.4M vs. $26.3M loss last year; operating income reached $8.0M from $57.4M loss in Q1 2025.
  • Stock rose 4.33% to $28.21 after-hours; company forecasts Q2 2026 EPS of $0.17, full-year EPS of $0.47, and Q2 revenue of $84M.
  • CEO Mason emphasized strategic focus on China and U.S. expansion; risks include economic conditions, regulatory changes, and currency fluctuations.
Last Updated: 13/05/2026, 23:34
Read Full Transcript

Earnings

Latest Release
13/05/2026
EPS / Forecast
0.10 / 0.05
Revenue / Forecast
93.5M / 78.74M
EPS Revisions
Last 90 days

Compare STAA to Peers and Sector

Metrics to compare
STAA
Peers
Sector
Relationship
P/E Ratio
−62.8x6.4x−0.4x
PEG Ratio
−0.92−0.240.00
Price/Book
3.8x3.0x2.6x
Price / LTM Sales
4.6x2.8x3.0x
Upside (Analyst Target)
6.1%54.8%49.7%
Fair Value Upside
Unlock15.5%7.3%Unlock

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
14.29M28.70%390.67M
Other Institutional Investors
64.05M71.30%1.75B
Public Companies & Retail Investors
0.000.00%0.00
Total
78.34M100.00%2.14B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Broadwood Capital, Inc.32.38%16,123,842440,826
Broadwood Partners LP32.38%16,123,842440,826

People Also Watch

97.91
ECHO
-0.39%
281.27
NTRA
-0.89%
418.91
CIEN
-3.44%
698.91
LITE
-4.42%
185.38
GLW
-4.84%

FAQ

What Is the STAAR Surgical (NASDAQ: STAA) Share Price Today?

The STAAR Surgical stock price today is 26.55 USD.

What Stock Exchange Does STAAR Surgical (STAA) Trade On?

STAAR Surgical is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for STAAR Surgical?

The stock symbol (also called a 'ticker') for STAAR Surgical is "STAA."

What Is the Current STAAR Surgical Market Capitalisation?

As of today, STAAR Surgical (NASDAQ: STAA) market cap is 1.32B USD.

What Is STAAR Surgical's (STAA) Earnings Per Share (TTM)?

The STAAR Surgical EPS is currently -0.42 (Trailing Twelve Months).

When Is the Next STAAR Surgical Earnings Date?

STAAR Surgical's next earnings report will be released on 12/08/2026.

Is STAA a Buy or Sell From a Technical Analyst Perspective?

Based on today's STAAR Surgical moving averages and other technical indicators, the daily buy/sell signal for STAA stock is Strong Sell.

How Many Times Has STAAR Surgical Stock Split?

STAAR Surgical has split 1 times. (See the STAA stock split history page for full effective split date and price information.)

How Many Employees Does STAAR Surgical Have?

STAAR Surgical has 921 employees, based on their latest Companies House report.

What is the current trading status of STAAR Surgical (NASDAQ: STAA)?

As of 08/07/2026, STAAR Surgical (STAA) is trading at a share price of 26.55 USD, with a previous close of 27.34 USD. The stock has fluctuated within a day range of 25.89 USD to 27.41 USD, while its 52-week range spans from 15.59 USD to 35.87 USD.

What Is STAAR Surgical (STAA) Price Target According to Analysts?

The average 12-month price target for STAAR Surgical is 29.67 USD, with a high estimate of 40 USD and a low estimate of 23 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +11.74% Upside potential.

What Is the STAA Premarket Price?

STAA's last pre-market stock price is 27.01 USD. The pre-market share volume is 30.00, and the stock has decreased by -0.33, or -1.21%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.